Speech Therapy For Parkinson'S Disease is a treatment approach for neurodegenerative diseases. This page provides comprehensive information about its mechanism of action, clinical evidence, and therapeutic potential.
Speech and voice disorders are among the most common and disabling non-motor symptoms of Parkinson's disease (PD), affecting up to 90% of patients during the course of the disease. Hypophonia (soft speech), monotone voice, dysarthria (slurred speech), and dysphagia (swallowing difficulties) significantly impact quality of life and social communication. Speech therapy interventions, particularly Lee Silverman Voice Treatment (LSVT), have demonstrated significant efficacy in improving vocal function.
The study of Speech Therapy For Parkinson'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: A comparison with untreated patients and normal age-matched controls. Movement Disorders. 2001.
[2] Sapir S, Ramig LO, Hoyt P, O'Brien C, Hoehn M. "Loud speech" therapy for persistent dysarthria in Parkinson's disease. Journal of Medical Speech-Language Pathology. 2002.
[3] Trail M, Fox C, Ramig LO, Sapir S, Howard J, Lai EC. Speech treatment effects demonstrated by positron emission tomography in PD. Neurology. 2005.
[4] Mahler LA, Ramig LO, Fox C. Evidence-based treatment of voice and speech disorders in Parkinson disease. ASHA Leader. 2009.
[5] Schalling E, Johansson K, Hartelius L. Speech and communication in Parkinson's disease: A 4-year prospective population study. Journal of Neurology. 2013.
[6] Andersen LM, Beer J. Intensive voice treatment for Parkinson's disease: A systematic review. International Journal of Speech-Language Pathology. 2018.
[7] Uppal NN, Chand P. Voice therapy in Parkinson's disease: A comprehensive review. Annals of Indian Academy of Neurology. 2020.
[8] El Sharkawi A, Ramig L, Logemann JA, et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): A pilot study. Journal of Neurology Neurosurgery Psychiatry. 2002.